시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 다한증 치료 시장 보고서(2025년)
Hyperhidrosis Treatment Global Market Report 2025
상품코드 : 1691903
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,339,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,163,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,987,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 다한증 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 예측 기간의 주요 동향으로서는 맞춤형 치료 어프로치, 의료기기의 기술 혁신, 경구약의 연구 개발, 진찰이나 경과 관찰을 위한 원격 의료, 공동 연구나 파트너십 등을 들 수 있습니다.

당뇨병 유병률의 상승은 향후 몇 년간의 다한증 치료 시장의 성장을 견인할 것으로 예상됩니다. 당뇨병은 채내에서 인슐린이 충분히 분비되지 않거나 인슐린이 적절히 반응하지 않는 경우에 발생하며, 혈당치(글루코스)의 상승을 초래합니다. 이 상태는 땀샘을 조절하는 신경을 손상시키고 과도한 발한과 다한증을 유발할 수 있습니다. 2024년 3월, 영국의 건강 개선 및 격차 대책실은 2022년 3월부터 2023년 3월까지, 추천되는 8개의 케어 프로세스를 모두 받은 1형 당뇨병 환자가 22% 증가했다고 보고했습니다 또한 2형 당뇨병에서는 21% 증가하고 HbA1c의 목표치를 달성한 사람의 비율은 37.9%에 달해, 전국 당뇨병 감사(NDA)가 보고한 가운데 과거 최고가 되었습니다.

헬스케어 지출 증가는 향후 몇 년간의 다한증 치료 시장의 성장을 가속할 것으로 예상됩니다. 이에 따라 다한증과 같은 증상과 환자의 일상생활과 전반적인 삶의 질에 대한 영향에 대한 인식도 높아지고 있습니다. 2022년 3월 메디케어 및 메디케이드 서비스센터(CMS)는 2021-2030년 국민의료비(NHE) 보고서를 발표해, 국민의료비는 매년 평균 5.1% 증가했으며, 2030년에는 약 6조 8,000억 달러에 달할 것으로 예측했습니다. 또한, 메디케어 지출은 연율 7.2% 증가, 메디케이드 지출은 동기간에 연율 5.6% 증가로 예측되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Hyperhidrosis is a medical condition characterized by excessive sweating beyond what is necessary for regulating the body's temperature. It can affect various areas of the body, such as the underarms, palms, and soles of the feet. Hyperhidrosis treatment involves medical interventions and therapies designed to alleviate or manage the symptoms associated with excessive sweating, aiming to enhance the quality of life for individuals affected by this condition.

The primary types of hyperhidrosis treatments include topical treatments, surgical interventions, botulinum toxin A injections, iontophoresis, laser treatments, and other therapeutic approaches. Topical treatments involve the application of agents directly to the skin to address hyperhidrosis symptoms. Surgical treatments may be considered for certain cases, and botulinum toxin A injections are utilized to reduce excessive sweating. Iontophoresis and laser treatments are additional methods used to manage hyperhidrosis. These treatments can be administered through various routes, including oral and injectable, to address specific types of hyperhidrosis, such as axillary, palmar, plantar, and others. Hyperhidrosis treatments are available through different distribution channels, including hospitals, ambulatory surgical centers, retail pharmacies, and online platforms.

The hyperhidrosis treatment market research report is one of a series of new reports from The Business Research Company that provides hyperhidrosis treatment market statistics, including hyperhidrosis treatment industry global market size, regional shares, competitors with a hyperhidrosis treatment market share, detailed hyperhidrosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hyperhidrosis treatment industry. This hyperhidrosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyperhidrosis treatment market size has grown strongly in recent years. It will grow from $1.58 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to cosmetic concerns, psychosocial impact awareness, regulatory support.

The hyperhidrosis treatment market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to patient-centric treatment approaches, global health awareness, advancements in topical therapies, innovations in surgical procedures, inclusion in comprehensive dermatology practices. Major trends in the forecast period include personalized treatment approaches, technological innovations in medical devices, research and development in oral medications, telemedicine for consultations and follow-ups, collaborations and partnerships.

The rising prevalence of diabetes mellitus is expected to drive the growth of the hyperhidrosis treatment market in the coming years. Diabetes mellitus occurs when the body either does not produce enough insulin or does not respond properly to it, leading to elevated blood sugar (glucose) levels. This condition can damage the nerves that control sweat glands, leading to excessive sweating or hyperhidrosis. Diabetes also affects the body's ability to regulate temperature and produce the necessary amount of sweat for cooling. For example, in March 2024, the Office for Health Improvement & Disparities in the UK reported a 22% increase in individuals with type 1 diabetes receiving all eight recommended care processes between March 2022 and March 2023. Additionally, for type 2 diabetes, the percentage rose by 21%, while the percentage of individuals achieving target HbA1c levels reached 37.9%, the highest ever reported by the National Diabetes Audit (NDA). As such, the growing prevalence of diabetes mellitus is contributing to the expansion of the hyperhidrosis treatment market.

Rising healthcare expenditures are expected to fuel the growth of the hyperhidrosis treatment market in the coming years. Healthcare expenditure refers to the spending on medical goods and services, including medical expenses, equipment, supplies, and pharmaceuticals. As healthcare spending increases, so does awareness of conditions like hyperhidrosis and its impact on patients' daily lives and overall quality of life. This includes the development of new treatment options, surgical procedures, and the management of related comorbidities. For instance, in March 2022, the Centers for Medicare & Medicaid Services (CMS) published the 2021-2030 National Health Expenditure (NHE) report, which predicted that national health spending would rise by an average of 5.1% annually, reaching approximately $6.8 trillion by 2030. Furthermore, Medicare expenditures are expected to grow at an annual rate of 7.2%, while Medicaid spending is projected to increase by 5.6% annually over the same period. As healthcare spending rises, it is expected to drive the expansion of the hyperhidrosis treatment market.

Key players within the hyperhidrosis treatment market are intensifying their efforts to introduce wipe formulations, strategically aiming to boost market revenues. Wipe formulations serve as a delivery method for applying medications or antiperspirants to the skin through pre-moistened wipes. These formulations effectively apply antiperspirant medication to alleviate excessive sweating. An illustration of this strategy can be seen with Maruho Co. Ltd.'s May 2022 launch of Rapifort Wipes 2.5% in Japan. These wipes feature glycopyrronium tosilate hydrate as an active component, reducing sweat production by impeding the activation of acetylcholine receptors in sweat glands. Application of this medication solution once daily to both underarms with a single-use non-woven cloth in each packet minimizes sweating. This convenient, hygienic single-use wipe addresses primary axillary hyperhidrosis, a condition characterized by unexplained excessive underarm sweating that can disrupt daily activities.

In June 2023, miraDry Inc., a United States-based company specializing in non-invasive hyperhidrosis treatment, entered into a partnership with the International Hyperhidrosis Society (IHhS). This collaboration is designed to facilitate cooperation between miraDry and the International Hyperhidrosis Society (IHhS) in order to enhance hyperhidrosis therapy. The partnership underscores miraDry's commitment to improving the lives of individuals experiencing excessive sweating. The International Hyperhidrosis Society (IHhS) is a non-profit organization based in the United States that serves millions of individuals affected by hyperhidrosis.

Major companies operating in the hyperhidrosis treatment market report are Pfizer Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, GSK PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Cynosure LLC, Ipsen SA, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Daewoong Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Kaken Pharmaceutical Co Ltd., Avanor Healthcare Ltd., HUGEL Inc., Evolus Inc., Revance Therapeutics Inc., Dermira Inc., Sesderma SL, Miramar Labs Inc., Dermavant Sciences Inc., Theravida Inc., SweatBlock, Brickell Biotech Inc., Fresh Tracks Therapeutics Inc., Advin Health Care Inc., Dermadry Laboratories Inc., Ulthera Inc., Dermata Therapeutics Inc.

North America was the largest region in the hyperhidrosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperhidrosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hyperhidrosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hyperhidrosis treatment market consists of revenues earned by entities by providing services such as microwave therapy, iontophoresis, sympathectomy, and sweat gland removal. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperhidrosis treatment market also includes sales of drysol, xerac AC, glycopyrrolate, benztropine and beta blockers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hyperhidrosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hyperhidrosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for hyperhidrosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hyperhidrosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Hyperhidrosis Treatment Market Characteristics

3. Hyperhidrosis Treatment Market Trends And Strategies

4. Hyperhidrosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Hyperhidrosis Treatment Growth Analysis And Strategic Analysis Framework

6. Hyperhidrosis Treatment Market Segmentation

7. Hyperhidrosis Treatment Market Regional And Country Analysis

8. Asia-Pacific Hyperhidrosis Treatment Market

9. China Hyperhidrosis Treatment Market

10. India Hyperhidrosis Treatment Market

11. Japan Hyperhidrosis Treatment Market

12. Australia Hyperhidrosis Treatment Market

13. Indonesia Hyperhidrosis Treatment Market

14. South Korea Hyperhidrosis Treatment Market

15. Western Europe Hyperhidrosis Treatment Market

16. UK Hyperhidrosis Treatment Market

17. Germany Hyperhidrosis Treatment Market

18. France Hyperhidrosis Treatment Market

19. Italy Hyperhidrosis Treatment Market

20. Spain Hyperhidrosis Treatment Market

21. Eastern Europe Hyperhidrosis Treatment Market

22. Russia Hyperhidrosis Treatment Market

23. North America Hyperhidrosis Treatment Market

24. USA Hyperhidrosis Treatment Market

25. Canada Hyperhidrosis Treatment Market

26. South America Hyperhidrosis Treatment Market

27. Brazil Hyperhidrosis Treatment Market

28. Middle East Hyperhidrosis Treatment Market

29. Africa Hyperhidrosis Treatment Market

30. Hyperhidrosis Treatment Market Competitive Landscape And Company Profiles

31. Hyperhidrosis Treatment Market Other Major And Innovative Companies

32. Global Hyperhidrosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hyperhidrosis Treatment Market

34. Recent Developments In The Hyperhidrosis Treatment Market

35. Hyperhidrosis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기